Autolus at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Autolus exhibits at Booth 2839 at ASH 2026 in New Orleans. Autolus supports a symposium on treatment sequencing in acute lymphoblastic leukemia. The debate runs from asparaginase through cellular therapy, with minimal residual disease testing shaping each step.
| Organization | ASH 2026 Attendance |
|---|---|
Autolus London, United Kingdom | |
CAR T-cell therapy company developing programmed autologous T-cell therapies for cancer and autoimmune disease. | Booth Exhibiting at Booth 2839 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm Medical Crossfire®: Strategic Sequencing in ALL — From Asparaginase to Cellular Therapy in an MRD-Driven Era Ordering acute lymphoblastic leukemia therapies, from asparaginase to bispecifics and CAR-T, guided by sensitive residual disease testing. |
Find decision makers at Autolus
Tell us what you sell and we’ll find the people at Autolus most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction